Pharmaceutical and Medicinal Chemistry Institute of Pharmacy and Food Chemistry, Julius Maximilian University of Würzburg, Am Hubland, 97074, Würzburg, Germany.
Department of Pharmacy and Biotechnology, University of Bologna, Via Belmeloro 6, 40126, Bologna, Italy.
ChemMedChem. 2020 Aug 5;15(15):1374-1389. doi: 10.1002/cmdc.202000298. Epub 2020 Jun 24.
Cannabinoid subtype 2 receptors (CB Rs) are G protein-coupled receptors (GPCRs) belonging to the endocannabinoid system, a complex network of signalling pathways leading to the regulation of key physiological processes. Interestingly, CB Rs are strongly up-regulated in pathological conditions correlated with the onset of inflammatory events like cancer and neurodegenerative diseases. Therefore, CB Rs represent an important biological target for therapeutic as well as diagnostic purposes. No CB R-selective drugs are yet on the market, thus underlining a that deeper comprehension of CB Rs' complex activation pathways and their role in the regulation of diseases is needed. Herein, we report an overview of pharmacological and imaging tools such as fluorescent, positron emission tomography (PET), photochromic and covalent selective CB R ligands. These molecular probes can be used in vitro as well as in vivo to investigate and explore the unravelled role(s) of CB Rs, and they can help to design suitable CB R-targeted drugs.
大麻素受体 2 型(CB Rs)是 G 蛋白偶联受体(GPCRs),属于内源性大麻素系统,这是一个复杂的信号通路网络,可调节关键的生理过程。有趣的是,CB Rs 在与炎症事件(如癌症和神经退行性疾病)相关的病理条件下强烈上调。因此,CB Rs 是治疗和诊断的重要生物靶点。目前市场上还没有 CB R 选择性药物,这表明需要更深入地了解 CB Rs 的复杂激活途径及其在疾病调节中的作用。本文综述了荧光、正电子发射断层扫描(PET)、光致变色和共价选择性 CB R 配体等药理学和成像工具。这些分子探针可在体外和体内用于研究和探索 CB Rs 的未揭示作用,并有助于设计合适的 CB R 靶向药物。